🇺🇸 Opioid Analgesics in United States
20 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 20
Most-reported reactions
- Anaemia Macrocytic — 2 reports (10%)
- Back Pain — 2 reports (10%)
- Cognitive Disorder — 2 reports (10%)
- Convulsion — 2 reports (10%)
- Diplopia — 2 reports (10%)
- Drug Interaction — 2 reports (10%)
- Extradural Abscess — 2 reports (10%)
- Optic Atrophy — 2 reports (10%)
- Optic Neuropathy — 2 reports (10%)
- Osteomyelitis — 2 reports (10%)
Frequently asked questions
Is Opioid Analgesics approved in United States?
Opioid Analgesics does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Opioid Analgesics in United States?
VA Office of Research and Development is the originator. The local marketing authorisation holder may differ — check the official source linked above.